Actualités HeartBeam Inc - BEAT | Actions NASDAQ

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia assessment The Company is gearing up...

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection...

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to...

HeartBeam Reports Third Quarter 2024 Results

Continued Clinical and Regulatory Progress on the HeartBeam System Key Appointments to Management Team Completed as Part of Planned Evolution in...

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever...

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical...

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth Founder and...

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Industry Leader, Former Head of Data Science at Verily (Google Life Sciences) and Globally Respected Authority on Artificial Intelligence (AI...

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Seasoned MedTech Leader with Proven Track Record of Strategic Planning, Financial Stewardship and Commercial Success HeartBeam, Inc. (NASDAQ:...

HeartBeam Reports Second Quarter 2024 Results

Continued Clinical and Regulatory Progress on the HeartBeam AIMIGo™ System Enrollment Complete in VALID-ECG Clinical Study That Will Be the Basis...

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights...

HeartBeam Added to Russell Microcap® Index

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights...

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI to VCG...

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies HeartBeam...

HeartBeam Reports First Quarter 2024 Results

Continued Clinical and Regulatory Progress on the AIMIGo™ 3D VECG System Presented Positive Results on its Artificial Intelligence Capabilities...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

HeartBeam Inc (BEAT)

Outils de qualité professionnelle, pour des investisseurs individuels.

BEAT Actualités

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

HeartBeam Reports Third Quarter 2024 Results

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

HeartBeam Reports Second Quarter 2024 Results

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

HeartBeam Added to Russell Microcap® Index

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

HeartBeam Reports First Quarter 2024 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

HeartBeam Inc (BEAT) Actualités

HeartBeam Inc (BEAT)

Outils de qualité professionnelle, pour des investisseurs individuels.

BEAT Actualités

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

HeartBeam Reports Third Quarter 2024 Results

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

HeartBeam Reports Second Quarter 2024 Results

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

HeartBeam Added to Russell Microcap® Index

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

HeartBeam Reports First Quarter 2024 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application